CYSTAGON Drug Patent Profile
✉ Email this page to a colleague
When do Cystagon patents expire, and what generic alternatives are available?
Cystagon is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in CYSTAGON is cysteamine bitartrate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteamine bitartrate profile page.
Summary for CYSTAGON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 10 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CYSTAGON |
What excipients (inactive ingredients) are in CYSTAGON? | CYSTAGON excipients list |
DailyMed Link: | CYSTAGON at DailyMed |
Recent Clinical Trials for CYSTAGON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NHS Grampian | Phase 1/Phase 2 |
University of Aberdeen | Phase 1/Phase 2 |
Cystic Fibrosis Trust | Phase 1/Phase 2 |
Pharmacology for CYSTAGON
Drug Class | Cystine Depleting Agent |
Mechanism of Action | Cystine Disulfide Reduction |
US Patents and Regulatory Information for CYSTAGON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | CYSTAGON | cysteamine bitartrate | CAPSULE;ORAL | 020392-001 | Aug 15, 1994 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | CYSTAGON | cysteamine bitartrate | CAPSULE;ORAL | 020392-002 | Aug 15, 1994 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |